EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence

Vera Ruíz Moleón iD, Charles Alende iD, Maryam Fothouhi, Sara González Bolívar iD, Riham Ayoubi, Vincent Francis iD, Peter S McPherson, Carl Laflamme iD

F1000Research · 2026

DOI: 10.12688/f1000research.179367.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2026. Verfasst von Vera Ruíz Moleón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, C…. Hauptthemen laut MEDLINE: Transcription Factors, Blotting, Western, Antibodies, Fluorescent Antibody Technique. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The AT-rich interactive domain-containing protein 2 (ARID2) is a core component of the chromatin-remodeling complex that regulates transcription by modulating nucleosome positioning. Here we have characterized six ARID2 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsBlotting, WesternAntibodiesFluorescent Antibody TechniqueImmunoprecipitationDNA-Binding ProteinsHumans

Stichwörter der Autor:innen

ARID2AT-Rich Interaction Domain 2Q68CP9antibody characterizationantibody validationimmunofluorescenceimmunoprecipitationwestern blot

Substanzen

Transcription FactorsAntibodiesDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.

ORCID-Profile: Vera Ruíz Moleón, Charles Alende, Sara González Bolívar, Vincent Francis, Carl Laflamme

Zitieren

APA

Moleón, V. R., Alende, C., Fothouhi, M., Bolívar, S. G., Ayoubi, R., Francis, V., McPherson, P. S., & Laflamme, C. (2026). A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.179367.1

Vancouver

Moleón VR, Alende C, Fothouhi M, Bolívar SG, Ayoubi R, Francis V, et al. A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2026. doi:10.12688/f1000research.179367.1

BibTeX
@article{Molen2026,
  author = {Moleón, Vera Ruíz and Alende, Charles and Fothouhi, Maryam and Bolívar, Sara González and Ayoubi, Riham and Francis, Vincent and McPherson, Peter S and Laflamme, Carl},
  title = {A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence},
  journal = {F1000Research},
  year = {2026},
  doi = {10.12688/f1000research.179367.1}
}
Kostenlos starten →